CSF oxytocin and vasopressin levels after recovery from bulimia nervosa and anorexia nervosa, bulimic subtype

Biological Psychiatry

Volumn 48, Issue 4, 2000, Pages 315-318

  Frank, Guido K ^a   Kaye, Walter H ^a   Altemus, Margaret ^b   Greeno, Catherine G ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Anorexia nervosa; Bulimia nervosa; Major depression; Obsessive compulsive disorder; Oxytocin; Vasopressin

Indexed keywords

NEUROPEPTIDE; ORAL CONTRACEPTIVE AGENT; OXYTOCIN; VASOPRESSIN;

ADULT; ANOREXIA NERVOSA; ARTICLE; BULIMIA; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; EATING DISORDER; FEMALE; HUMAN; MENSTRUAL CYCLE; OBSESSION; PRIORITY JOURNAL;

ADULT; ANOREXIA NERVOSA; BULIMIA; FEMALE; HUMANS; OXYTOCIN; TIME FACTORS; VASOPRESSINS;

EID: 0034663356     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)00243-2     Document Type: Article

References (27)

1. Altemus M., Jacobson K.R., Debellis M., Kling M., Pigott T., Murphy D.L., et al. Normal CSF oxytocin and NPY in OCD. Biol Psychiatry. 45:1999;931-933.
2. Altemus M., Swedo S.E., Leonard H.L., Richter D., Rubinow D., Potter W., et al. Changes in cerebrospinal fluid neurochemistry of obsessive-compulsive disorder with clomipramine. Arch Gen Psychiatry. 51:1994;794-803.
3. American Psychiatric Association (1994): Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Press.
4. Amico J.A., Janosky J.E., Cameron J.L. Effect of estradiol and progesterone administration upon the circadian rhythm of oxytocin in the cerebrospinal fluid of rhesus monkeys. Neuroendocrinology. 51:1990;543-551.
5. Barcikowski, Robert S, editors (1984): Computer Packages and Research Design, vol. 3: SPSS & SPSSX. Lanham, MD: University Press of America.
6. Burlet A., Desor D., Max J.P., Nicolas J.P., Krafft B., Burlet C. Ingestive behaviors of the rat deficient in vasopressin synthesis (Brattleboro strain). Effect of chronic treatment by dDAVP. Physiol Behav. 48:1990;813-819.
7. Demitrack M.A., Kalogeras K.T., Altemus M., Pigott T.A., Listwak S.J., Gold P.W. Plasma and cerebrospinal fluid measures of arginine vasopressin secretion in patients with bulimia nervosa and in healthy subjects. J Clin Endocrinol Metab. 74:1992;1277-1283.
8. Demitrack M.A., Lesem M.D., Listwak S.J., Brandt H.A., Jimerson D.C., Gold P.W. CSF oxytocin in anorexia nervosa and bulimia nervosa Clinical and pathophysiological considerations . Am J Psychiatry. 147:1990;882-886.
9. Garfinkel P.E., Kennedy S.H., Kaplan A.S. Views on classification and diagnosis of eating disorders. Can J Psychiatry. 40:1995;445-456.
10. Geiner H., Altstein M., Whitnall W.S. The biosynthesis and secretion of oxytocin and vasopressin. Knobil E., Neill J. The Physiology of Reproduction. 1988;2265-2281 Raven, New York.
11. Gjerris A., Hammer M., Vendsborg P., Christensen N.J., Rafaelsen O.J. Cerebrospinal fluid vasopressin changes in depression. Br J Psychiatry. 147:1985;696-701.
12. Gold P.W., Kaye W.H., Robertson G.L., Ebert M.H. Abnormalities in plasma and cerebrospinal-fluid arginine vasopressin in patients with anorexia nervosa. N Engl J Med. 308:1983;1117-1123.
13. Gold P.W., Robertson G.L., Ballenger J.C., Rubinow D.R., Kellner C.R., Post R.M., et al. Neurohypophyseal function in affective illness. Psychopharmacol Bull. 19:1983;426-431.
14. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., et al. The Yale-Brown Obsessive Compulsive Scale (YBOCS) I. Development, use and reliability . Arch Gen Psychiatry. 46:1989;1006-1011.
15. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 6:1967;278-296.
16. Insel T.R., Young L., Wang Z. Central oxytocin and reproductive behaviors. Rev Reprod. 2:1997;28-37.
17. Jolkkonen J., Tuomisto L., van Wimersma Greidanus T.B., Laara E., Riekkinen P.J. Vasopressin levels in the cerebrospinal fluid in rats of different age and sex. Neuroendocrinology. 44:1986;163-167.
18. Kaye W.H., Gendall K., Kye C. The role of the central nervous system in the psychoneuroendocrine disturbances of anorexia and bulimia nervosa. Psychiatr Clin North Am. 21:1998;381-395.
19. Kaye W.H., Greeno C.G., Moss H., Fernstrom J., Fernstrom M., Lilenfeld L.R., et al. Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa. Arch Gen Psychiatry. 55:1998;927-935.
20. Leckman J.F., Goodman W.K., North W.G., Chappell P.B., Price L.H., Pauls D.L., et al. Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Arch Gen Psychiatry. 51:1994;782-792.
21. Liebsch G., Wotjak C.T., Landgraf R., Engelmann M. Septal vasopressin modulates anxiety related behavior in rats. Neurosci Lett. 217:1996;101-104.
22. McCarthy M.M., McDonald C.H., Brooks P.J., Goldman D. An anxiolytic action of oxytocin is enhanced by estrogen in the mouse. Physiol Behav. 60:1995;1209-1215.
23. New weight standards for men and women. Stat Bull Metropolitan Insur Company. 40:1959;1-11.
24. Olson B.R., Drutarosky M.D., Chow M.-S., Hruby V.J., Stricker E.M., Verbalis J.G. Oxytocin and oxytocin agonist administered centrally decrease food intake in rats. Peptides. 12:1991;113-118.
25. Parry B.L., Gerner R.H., Wilkins J.N., Halaris A.E., Carlson H.E., Hershman J.M., et al. CSF and endocrine studies of premenstrual syndrome. Neuropsychopharmacology. 5:1991;127-137.
26. Sorensen P.S., Gjerris A., Hammer M. Cerebrospinal fluid vasopressin in neurological and psychiatric disorders. J Neurol Psychiatry. 48:1985;50-57.
27. Swaab D.F., Hofman M.A., Lucassen P.J., Purba J.S., Raadsheer F.C., Van de Nes J.A.P. Functional neuroanatomy and neuropathology of the human hypothalamus. Anat Embryol. 187:1993;317-330.